SUMO1 and breast cancer: To further confirm that SUMO1-mediated SUMOylation was responsible for the loss of cell viability observed in the presence of GA, we used a specific pool of siRNAs to deplete SUMO1 over 72 h (Fig. 1I) in the triple-negative MDA-MB-231 breast cancer cell line, a particularly aggressive subtype of breast cancer.